178 related articles for article (PubMed ID: 17013831)
1. High-affinity triplex-forming oligonucleotide target sequences in mammalian genomes.
Wu Q; Gaddis SS; MacLeod MC; Walborg EF; Thames HD; DiGiovanni J; Vasquez KM
Mol Carcinog; 2007 Jan; 46(1):15-23. PubMed ID: 17013831
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
3. A web-based search engine for triplex-forming oligonucleotide target sequences.
Gaddis SS; Wu Q; Thames HD; DiGiovanni J; Walborg EF; MacLeod MC; Vasquez KM
Oligonucleotides; 2006; 16(2):196-201. PubMed ID: 16764543
[TBL] [Abstract][Full Text] [Related]
4. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
[TBL] [Abstract][Full Text] [Related]
5. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment.
Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C
Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289
[TBL] [Abstract][Full Text] [Related]
6. Triplex targets in the human rhodopsin gene.
Perkins BD; Wilson JH; Wensel TG; Vasquez KM
Biochemistry; 1998 Aug; 37(32):11315-22. PubMed ID: 9698379
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM
Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376
[TBL] [Abstract][Full Text] [Related]
8. Purine- and pyrimidine-triple-helix-forming oligonucleotides recognize qualitatively different target sites at the ribosomal DNA locus.
Maldonado R; Filarsky M; Grummt I; Längst G
RNA; 2018 Mar; 24(3):371-380. PubMed ID: 29222118
[TBL] [Abstract][Full Text] [Related]
9. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P
Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156
[TBL] [Abstract][Full Text] [Related]
10. High-efficiency triple-helix-mediated photo-cross-linking at a targeted site within a selectable mammalian gene.
Vasquez KM; Wensel TG; Hogan ME; Wilson JH
Biochemistry; 1996 Aug; 35(33):10712-9. PubMed ID: 8718860
[TBL] [Abstract][Full Text] [Related]
11. Modulation of psoralen DNA crosslinking kinetics associated with a triplex-forming oligonucleotide.
Oh DH; Suzara V; Krishnan R
Photochem Photobiol; 2008; 84(3):727-33. PubMed ID: 18435621
[TBL] [Abstract][Full Text] [Related]
12. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
13. Triplex-stimulated intermolecular recombination at a single-copy genomic target.
Knauert MP; Kalish JM; Hegan DC; Glazer PM
Mol Ther; 2006 Sep; 14(3):392-400. PubMed ID: 16731047
[TBL] [Abstract][Full Text] [Related]
14. Targeting DNA with triplex-forming oligonucleotides to modify gene sequence.
Simon P; Cannata F; Concordet JP; Giovannangeli C
Biochimie; 2008 Aug; 90(8):1109-16. PubMed ID: 18460344
[TBL] [Abstract][Full Text] [Related]
15. Targeted gene knockout mediated by triple helix forming oligonucleotides.
Majumdar A; Khorlin A; Dyatkina N; Lin FL; Powell J; Liu J; Fei Z; Khripine Y; Watanabe KA; George J; Glazer PM; Seidman MM
Nat Genet; 1998 Oct; 20(2):212-4. PubMed ID: 9771719
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a triplex-forming oligonucleotide-pyrrolobenzodiazepine conjugate.
Zhilina ZV; Ziemba AJ; Trent JO; Reed MW; Gorn V; Zhou Q; Duan W; Hurley L; Ebbinghaus SW
Bioconjug Chem; 2004; 15(6):1182-92. PubMed ID: 15546183
[TBL] [Abstract][Full Text] [Related]
17. Targeted genome modification via triple helix formation.
Kalish JM; Glazer PM
Ann N Y Acad Sci; 2005 Nov; 1058():151-61. PubMed ID: 16394134
[TBL] [Abstract][Full Text] [Related]
18. Characterization and quantification of triple helix formation in chromosomal DNA.
Besch R; Giovannangeli C; Schuh T; Kammerbauer C; Degitz K
J Mol Biol; 2004 Aug; 341(4):979-89. PubMed ID: 15328613
[TBL] [Abstract][Full Text] [Related]
19. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure.
Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T
Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770
[TBL] [Abstract][Full Text] [Related]
20. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
Taniguchi Y; Sasaki S
Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
